Search Results for: log in

HLTH Interview: BioReference’s COVID-19 Response

As the entire world is feeling the effects of the coronavirus (COVID-19), we are thankful for the healthcare community, especially to those on the frontlines. On May 15, Dr. Jon Cohen, BioReference’s Executive Chairman spoke with HLTH, a large-scale forum for collaboration across senior leaders from established payers, providers, employers, pharma, startups, and investors, as […]

Allergens are in the Air

Coughing. Sneezing. Itchy eyes. Runny nose. Scratchy throat. All common signs that allergy season is in full bloom. In severe cases, allergic reactions can also include rashes, hives, low blood pressure, breathing trouble, asthma attacks. May is National Asthma and Allergy Awareness Month, and a peak time to educate patients, family, friends, co-workers and others […]

MagnaCare and BioReference Laboratories Bring COVID-19 Antibody Testing to New York Labor Groups

Collaboration supports return-to-work planning for key workforce groups NEW YORK (May 18, 2020) – MagnaCare today announced a collaboration with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), to bring COVID-19 antibody testing to their Labor clients in the New York metropolitan area. Through this collaboration with BioReference, MagnaCare will offer on-site antibody blood […]

Some back-of-the-envelope math reveals the risk in relying on even the best antibody tests to tell us who’s had the coronavirus

Business Insider Medical tests, like the blood tests that look for antibodies to the novel coronavirus, aren’t perfect. Sometimes, you end up with a false negative: You actually did have the coronavirus and your immune system developed antibodies to the virus, but the test says you don’t have those antibodies. Other times, you end up with […]

OPKO Health’s BioReference Laboratories Launches COVID-19 Employer Solution

BioReference provides employers with flexible program options for employee screening ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched the BioReference Employer Solution, a COVID-19 screening program that assists employers’ decisions about return-to-work policies. Test results play a critical role in the fight against COVID-19 by identifying […]

Employers and Government Authorities

OPKO Health’s BioReference Laboratories and Westchester Medical Center Health Network Enter Into Strategic Laboratory Collaboration to Deliver Operational and Diagnostic Services

ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a strategic collaboration with the Westchester Medical Center Health Network (WMCHealth), a 1,700-bed healthcare system headquartered in Valhalla, New York, to provide full laboratory administrative services, laboratory operations, reference testing and outpatient laboratory services. WMCHealth has 10 hospitals […]

How many people need to be tested, traced before NJ moves closer to reopening?

USA Today New Jersey aims to double its COVID-19 testing capacity to close to 20,000 people a day by the end of May as officials weigh the decision to relax monthslong restrictions and reopen the economy, Gov. Phil Murphy announced Tuesday. The state also plans to recruit at least 1,000 more contact tracers and pay them to track the movements […]

Covid-19 Antibody Tests Are Easy to Get But It’s Not Clear What They’re Telling Us

Bloomberg There’s no hard evidence that antibodies to the virus that causes Covid-19 provide immunity Covid-19 antibody tests are suddenly everywhere. A West Palm Beach spa that normally offers Botox and collagen treatments touts tests on Instagram. A New York City urgent-care chain emails patients that the tests are available, though “not 100% accurate.” A chiropractic clinic in […]

COVID-19 testing problems started early, U.S. still playing from behind

Modern Healthcare NEW YORK – Four months since the first COVID-19 case was reported in the U.S., the demand for testing for the SARS-CoV-2 virus still far outpaces the supply, even as test developers scramble to increase their testing capacity and new types of tests make their way into the market. Despite assurances early on […]